These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 10696975)

  • 41. [Various enzyme and functional tests in patients with chronic cholecystitis before and after cholecystectomy].
    Diachina EG
    Vestn Khir Im I I Grek; 1969 Feb; 102(2):22-5. PubMed ID: 5796613
    [No Abstract]   [Full Text] [Related]  

  • 42. Relationship between aminotransferase levels and histopathological findings in patients with nonalcoholic steatohepatitis.
    Sonsuz A; Basaranoglu M; Ozbay G
    Am J Gastroenterol; 2000 May; 95(5):1370-1. PubMed ID: 10811364
    [No Abstract]   [Full Text] [Related]  

  • 43. Serum transaminase activity in leprosy in relation to liver damage.
    Shivde AV; Junnarkar RV
    Int J Lepr Other Mycobact Dis; 1967; 35(3):366-74. PubMed ID: 5630357
    [No Abstract]   [Full Text] [Related]  

  • 44. [Increased transaminases--differential diagnosis and evaluation].
    Elke B; Battegay E; Müllhaupt B
    Praxis (Bern 1994); 2008 May; 97(11):587-96; quiz 596-7. PubMed ID: 18592953
    [No Abstract]   [Full Text] [Related]  

  • 45. [Advances in the enzymatic diagnosis of hepatobiliary diseases].
    Calvo C
    Rev Med Chil; 1984 Apr; 112(4):379-85. PubMed ID: 6148781
    [No Abstract]   [Full Text] [Related]  

  • 46. [Selection of liver function tests for diagnosis of various liver diseases].
    Nihon Naika Gakkai Zasshi; 1990 Aug; 79(8):1059-68. PubMed ID: 1700046
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinico-diagnostic significance of protein indices and blood enzyme activity in focal liver diseases].
    Gaevskaia VA; Pokrasen NM
    Vrach Delo; 1988 Sep; (9):22-5. PubMed ID: 3212986
    [No Abstract]   [Full Text] [Related]  

  • 48. A diagnostic triad for portal cirrhosis.
    Goldberg DM; Ellis G; Ward AM
    Clin Chim Acta; 1976 Nov; 72(3):379-82. PubMed ID: 975589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Liver diseases from the viewpoint of laboratory findings].
    Rösler-Englhardt A
    Med Klin; 1976 Sep; 71(36):1413-21. PubMed ID: 958104
    [No Abstract]   [Full Text] [Related]  

  • 50. Persistent increase in aspartate aminotransferase in an asymptomatic patient.
    Krishnamurthy S; Korenblat KM; Scott MG
    Clin Chem; 2009 Aug; 55(8):1573-5. PubMed ID: 19638492
    [No Abstract]   [Full Text] [Related]  

  • 51. [Serologic examinations of blood donors. III. Detection of liver damage in the blood of blood donors].
    Falser N
    Infusionstherapie (1973); 1974 Dec; 1(8):666-70. PubMed ID: 4142947
    [No Abstract]   [Full Text] [Related]  

  • 52. Liver function tests in buffalo calf.
    Sethuraman V; Verma BB
    Indian Vet J; 1979 Apr; 56(4):284-8. PubMed ID: 489107
    [No Abstract]   [Full Text] [Related]  

  • 53. [New diagnostic directions in liver disease. The value of studying "parallel enzyme constellations"].
    Terzani G; Seganti G; Recchia O; Pica R; Ruggia R
    Clin Ter; 1981 Apr; 97(1):17-26. PubMed ID: 7285529
    [No Abstract]   [Full Text] [Related]  

  • 54. Abnormal Liver Enzymes.
    Melendez-Rosado J; Alsaad A; Stancampiano FF; Palmer WC
    Gastroenterol Nurs; 2018; 41(6):497-507. PubMed ID: 30418344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Abnormal findings on liver function tests. Interpreting results to narrow the diagnosis and establish a prognosis.
    Gopal DV; Rosen HR
    Postgrad Med; 2000 Feb; 107(2):100-2, 105-9, 113-4. PubMed ID: 10689411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How to respond to abnormal liver function tests.
    Collier J; Bassendine M
    Clin Med (Lond); 2002; 2(5):406-9. PubMed ID: 12448585
    [No Abstract]   [Full Text] [Related]  

  • 57. [The general practitioner and abnormal liver function tests].
    Hallez R
    Rev Med Brux; 1997 Sep; 18(4):178-82. PubMed ID: 9411638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Reestimation of aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio based on JSCC consensus method--changes of criteria for a differential diagnosis of hepatic disorders following the alteration from Karmen method to JSCC method].
    Kotani K; Maekawa M; Kanno T
    Nihon Shokakibyo Gakkai Zasshi; 1994 Feb; 91(2):154-61. PubMed ID: 8114321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine.
    Sookoian S; Pirola CJ
    World J Gastroenterol; 2015 Jan; 21(3):711-25. PubMed ID: 25624707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [On the value of the ceruloplasmin determination in the enzyme diagnosis of liver diseases].
    Lorentz K
    Schweiz Med Wochenschr; 1969 Apr; 99(16):600-2. PubMed ID: 5768020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.